Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Baxter
McKinsey
Federal Trade Commission
QuintilesIMS
Covington

Generated: July 23, 2019

DrugPatentWatch Database Preview

Litigation Details for Ferring BV v. Teva Pharmaceuticals (D. Del. 2004)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Ferring BV v. Teva Pharmaceuticals (D. Del. 2004)

Docket ➤ Sign Up Date Filed 2004-07-20
Court District Court, D. Delaware Date Terminated 2008-01-16
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties FERRING BV; TEVA PHARMACEUTICALS INDUSTRIES, LTD.; TEVA PHARMACEUTICALS U.S.A., INC.
Patents 3,497,491; 5,047,398; 5,427,798; 5,500,413; 5,763,407
Attorneys Christine A. Pepe; Dennis J. Mondolino; Francis DiGiovanni; Josy W. Ingersoll
Link to Docket External link to docket
Small Molecule Drugs cited in Ferring BV v. Teva Pharmaceuticals
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .

Details for Ferring BV v. Teva Pharmaceuticals (D. Del. 2004)

Date Filed Document No. Description Snippet Link To Document
2004-07-20 3 Patent/Trademark Report to Commissioner Report to Commissioner of Patents and Trademarks. Exit original. RE: 5,047,398 (els) (Entered: 07/21/2004…2004 16 January 2008 1:04-cv-00884 830 Patent None District Court, D. Delaware External link to document
2005-03-15 40 Exhibit F discussed, including U.S. Patent No. 3,497,491 to Zaoral (“the Zaoral patent”), but no agreement was reached…Undis}guted Facts No. 1: 'I`he ‘398 patent issued from a patent application Serial No. 809,937 (“the …‘398 patent prosecution history. ` Many, but not all, of the missing portions of the ‘398 patent prosecution…. Department of Cornrnerce, Patent and Tradeniark Office, Manual of Patent Exarnining Procedure (MPEP)…reconsideration reargued that the claims of the ‘398 patent were patentable based on the record and several newly submitted External link to document
2005-07-15 51 Redacted Document allowed to continue to enforce U.S. Patent No. 5,047,398 (the “‘398 patent”) in plain violation of an Order…proceedings including patent~related matters such as patent challenge settlements and patent infringement cases…that the ‘398 patent Was unenforceable due to misconduct in the prosecution of that patent in front of … the finding of another district court that the patent at issue is unenforceable due to inequitable conduct…the Southern District ofNew Yorl< finding that patent to be unenforceable Second, as of Jauuary l, 2006 External link to document
2005-08-19 56 Stipulation alleging that Teva infringed U.S. Patent No. 5,047,398 (“‘398 patent”) by filing Abbreviated New Drug… 08/19/2005 Page 3 of 3 States Patent Nos. 5,047,398, 5,500,413, 5,647,850 and 5,763,407. If …evidentiary purpose on the issues of patent validity, enforceability or patent infringement. 6. … WHEREAS, plaintiff Ferring has filed a patent infringement lawsuit, C.A. 04-884-SLR (“the Action… Product”) prior to the expiration of the ‘398 patent; and WHEREAS, Teva has filed a counterclaim External link to document
2005-08-24 57 Order alleging that Teva infringed U.S. Patent No. 5,047,398 (“‘398 patent”) by filing Al)breviated New Drug…57 Filed 08/24/2005 Page 3 of 3 States Patent Nos. 5,047,398, 5,500,413, 5,647,850 and 5,763,407. lfthis…evidentiary purpose on the issues of patent validity, enforceability or patent infringement. 6. Teva shall provide…follows: WHEREAS, plaintiff Ferring has filed a patent infringement lawsuit, C.A. 04-884-SLR (“the Action…ANDA Product”) prior to the expiration oftlie ‘398 patent; and WHEREAS, Teva has filed a counterclaim in External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Colorcon
Medtronic
Cipla
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.